Literature DB >> 15051329

Oxidative stress and antioxidant defenses: a target for the treatment of diseases caused by parasitic protozoa.

Julio F Turrens1.   

Abstract

Parasitic protozoa cause several diseases, affecting hundreds of millions, particularly in underdeveloped countries. Although these organisms are eukaryotic cells, some of them present major differences with their mammalian host in selected metabolic pathways. These differences may be exploited as targets for developing better pharmacological agents for the treatment of specific parasitic diseases. This review describes some of the differences in terms of antioxidant defenses between these organisms and their mammalian host, which may provide useful targets for the treatment of these diseases. Some of the potential targets are: (i). iron metabolism in Plasmodium, (ii). the presence of a Fe-containing form of superoxide dismutase in trypanosomatids and malaria-causing parasites, (iii). the unique trypanothione-dependent antioxidant metabolism in trypanosomatids, (iv). the ascorbate peroxidase found in Trypanosoma cruzi and perhaps present in other trypanosomatids.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15051329     DOI: 10.1016/j.mam.2004.02.021

Source DB:  PubMed          Journal:  Mol Aspects Med        ISSN: 0098-2997


  49 in total

1.  Induction of oxidative stress in Trypanosoma brucei by the antitrypanosomal dihydroquinoline OSU-40.

Authors:  Shanshan He; Alex Dayton; Periannan Kuppusamy; Karl A Werbovetz; Mark E Drew
Journal:  Antimicrob Agents Chemother       Date:  2012-02-06       Impact factor: 5.191

2.  Molecular Cloning and Biochemical Characterization of Iron Superoxide Dismutase from Leishmania braziliensis.

Authors:  Camila C B Brito; Fernando V Maluf; Gustavo M A de Lima; Rafael V C Guido; Marcelo S Castilho
Journal:  Mol Biotechnol       Date:  2018-08       Impact factor: 2.695

3.  Autophagic elimination of Trypanosoma cruzi in the presence of metals.

Authors:  Laís Pessanha de Carvalho; Edésio José Tenório de Melo
Journal:  J Microbiol       Date:  2019-08-28       Impact factor: 3.422

4.  Phenyl-alpha-tert-butyl nitrone reverses mitochondrial decay in acute Chagas' disease.

Authors:  Jian-Jun Wen; Vandanajay Bhatia; Vsevolod L Popov; Nisha Jain Garg
Journal:  Am J Pathol       Date:  2006-12       Impact factor: 4.307

5.  Iron superoxide dismutases in eukaryotic pathogens: new insights from Apicomplexa and Trypanosoma structures.

Authors:  Isabelle Q H Phan; Douglas R Davies; Nilmar Silvio Moretti; Dhanasekaran Shanmugam; Igor Cestari; Atashi Anupama; James W Fairman; Thomas E Edwards; Kenneth Stuart; Sergio Schenkman; Peter J Myler
Journal:  Acta Crystallogr F Struct Biol Commun       Date:  2015-05-07       Impact factor: 1.056

6.  Novel 3-nitro-1H-1,2,4-triazole-based amides and sulfonamides as potential antitrypanosomal agents.

Authors:  Maria V Papadopoulou; William D Bloomer; Howard S Rosenzweig; Eric Chatelain; Marcel Kaiser; Shane R Wilkinson; Caroline McKenzie; Jean-Robert Ioset
Journal:  J Med Chem       Date:  2012-05-23       Impact factor: 7.446

7.  Peptide aptamer mimicking RAD51-binding domain of BRCA2 inhibits DNA damage repair and survival in Trypanosoma brucei.

Authors:  Mack Hall; Smita Misra; Minu Chaudhuri; Gautam Chaudhuri
Journal:  Microb Pathog       Date:  2011-02-03       Impact factor: 3.738

8.  Effects of a putrescine analog on Giardia lamblia.

Authors:  C Maia; A Lanfredi-Rangel; K G Santana-Anjos; M F Oliveira; W De Souza; M A Vannier-Santos
Journal:  Parasitol Res       Date:  2008-04-24       Impact factor: 2.289

9.  Molecular characterization of cytosolic and mitochondrial tryparedoxin peroxidase in Trypanosoma cruzi populations susceptible and resistant to benznidazole.

Authors:  Fernanda B Nogueira; Jerônimo C Ruiz; Carlos Robello; Alvaro J Romanha; Silvane M F Murta
Journal:  Parasitol Res       Date:  2008-11-19       Impact factor: 2.289

10.  Antiparasitic Effect of Vitamin B12 on Trypanosoma cruzi.

Authors:  Alejandra B Ciccarelli; Fernanda M Frank; Vanesa Puente; Emilio L Malchiodi; Alcira Batlle; Maria Elisa Lombardo
Journal:  Antimicrob Agents Chemother       Date:  2012-08-06       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.